Search research articles
Contact Us
Filters
Showing results (111-120 of 122) with videos related to
Page
of 13
Sort By:
ACS Central Science
|
January 7, 2017
Why Do Membranes of Some Unhealthy Cells Adopt a Cubic Architecture?
Qi Xiao, Zhichun Wang, Dewight Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 15, 2020
A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo
Evelyn M Covés-Datson, Steven R King, Maureen Legendre, et al.
Genome Research
|
May 10, 2013
HIV infection reveals widespread expansion of novel centromeric human endogenous retroviruses
Rafael Contreras-Galindo, Mark H Kaplan, Shirley He, et al.
Scientific Reports
|
January 13, 2021
Targeted disruption of pi-pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activity
Evelyn M Covés-Datson, Steven R King, Maureen Legendre, et al.
Nature Microbiology
|
August 31, 2016
Intermediate filaments enable pathogen docking to trigger type 3 effector translocation
Brian C Russo, Luisa M Stamm, Matthijs Raaben, et al.
Scientific Reports
|
January 11, 2013
Murine colitis is mediated by vimentin
Nirit Mor-Vaknin, Maureen Legendre, Yue Yu, et al.
The Journal of Biological Chemistry
|
May 7, 2020
The role of the histone H3 variant CENPA in prostate cancer
Anjan K Saha, Rafael Contreras-Galindo, Yashar S Niknafs, et al.
Plos Neglected Tropical Diseases
|
July 30, 2019
Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin
Evelyn M Covés-Datson, Julie Dyall, Lisa Evans DeWald, et al.
Nature Communications
|
February 7, 2017
DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis
Nirit Mor-Vaknin, Anjan Saha, Maureen Legendre, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 30, 2017
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy
Nirit Mor-Vaknin, Miguel Rivas, Maureen Legendre, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 122) with videos related to
Sort By:
Page
of 13
ACS Central Science
|
January 7, 2017
Why Do Membranes of Some Unhealthy Cells Adopt a Cubic Architecture?
Qi Xiao, Zhichun Wang, Dewight Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 15, 2020
A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo
Evelyn M Covés-Datson, Steven R King, Maureen Legendre, et al.
Genome Research
|
May 10, 2013
HIV infection reveals widespread expansion of novel centromeric human endogenous retroviruses
Rafael Contreras-Galindo, Mark H Kaplan, Shirley He, et al.
Scientific Reports
|
January 13, 2021
Targeted disruption of pi-pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activity
Evelyn M Covés-Datson, Steven R King, Maureen Legendre, et al.
Nature Microbiology
|
August 31, 2016
Intermediate filaments enable pathogen docking to trigger type 3 effector translocation
Brian C Russo, Luisa M Stamm, Matthijs Raaben, et al.
Scientific Reports
|
January 11, 2013
Murine colitis is mediated by vimentin
Nirit Mor-Vaknin, Maureen Legendre, Yue Yu, et al.
The Journal of Biological Chemistry
|
May 7, 2020
The role of the histone H3 variant CENPA in prostate cancer
Anjan K Saha, Rafael Contreras-Galindo, Yashar S Niknafs, et al.
Plos Neglected Tropical Diseases
|
July 30, 2019
Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin
Evelyn M Covés-Datson, Julie Dyall, Lisa Evans DeWald, et al.
Nature Communications
|
February 7, 2017
DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis
Nirit Mor-Vaknin, Anjan Saha, Maureen Legendre, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 30, 2017
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy
Nirit Mor-Vaknin, Miguel Rivas, Maureen Legendre, et al.
Page
of 13